The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Collegium Pharmaceutical, Inc(NASDAQ:COLL) 
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR, which are extended-release and immedia...
Website: http://www.collegiumpharma.com
Founded: 2002
Full Time Employees: 255
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Collegium Pharmaceutical Days Payable Outstanding ttm (DPO)
Collegium Pharmaceutical Days Receivable Outstanding ttm (DSO)
Collegium Pharmaceutical Days Inventory Outstanding ttm (DIO)
Collegium Pharmaceutical Op Cashflow Per Share ttm
Collegium Pharmaceutical Free Cashflow Per Share ttm
Collegium Pharmaceutical Cash Per Share ttm
Collegium Pharmaceutical P/S ratio ttm
Collegium Pharmaceutical (GAAP) P/E ratio ttm
Collegium Pharmaceutical P/B ratio ttm
No extra charts and metrics for this ticker.